Alerts will be sent to your verified email
Verify Email
SAKAR
|
Sakar Healthcare
|
Gufic Biosciences
|
Caplin Point Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
9.28 % | 25.05 % | 20.61 % |
|
5yr Avg Net Profit Margin
|
10.38 % | 10.9 % | 24.8 % |
|
Price to Book
|
2.59 | 6.06 | 9.42 |
|
P/E
|
37.43 | 58.83 | 45.43 |
|
5yr Avg Cash Conversion Cycle
|
-14.29 Days | 26.94 Days | 79.85 Days |
|
5yr Average Interest Coverage Ratio
|
5.43 | 13.1 | 579.71 |
|
5yr Avg ROCE
|
10.08 % | 27.25 % | 25.27 % |
|
5yr Avg Operating Profit Margin
|
24.06 % | 18.45 % | 30.87 % |
|
5 yr average Debt to Equity
|
0.47 | 0.51 | 0.01 |
|
5yr CAGR Net Profit
|
3.94 % | 14.26 % | 16.28 % |
|
5yr Average Return on Assets
|
5.37 % | 11.52 % | 17.7 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.86 % | 72.52 % | 70.56 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-14.68 % | -2.48 % | 1.68 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 2.35 % | 0.87 % |
|
Sakar Healthcare
|
Gufic Biosciences
|
Caplin Point Lab
|
|---|